Manorama Industries Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Manorama Industries Ltd trades at ₹1,739, in a confirmed uptrend and 18 weeks into that stage. That is +20.3% against its own 200-day average. It sits at 100% of a 52-week range of ₹1,095 to ₹1,739. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks.

Today the stock is in a confirmed uptrend — week 18 of stage 2, confirmed. At ₹1,739 it trades +20.3% versus its 200-day average and sits at 100% of its 52-week range (₹1,095–₹1,739).

Against the market, two honest reads. Cumulative: over the last 7.9 years the stock moved +4,550% while the NIFTY 500 moved +170% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Story check

Manorama Industries Ltd's story is not scored yet against the markers our research file set on 14 June 2026. Where it sits in its own cycle: EXPANSION_STARTED. Still open: Trailing PE of 41.5x looks compressed (36th %ile) but at mid-cycle OPM the normalized PE is 66x (81st %ile) — the low multiple is an EPS-inflated illusion, not a trough.

Our read, 14 June 2026. A specialty-fats compounder that delivered 76% FY26 revenue growth — but margins are at a 74th-percentile peak (cycle_normalized: PEAK_MARGIN_VALUE_TRAP), management has accrued seven cross-call contradictions across four concalls, and the ₹460 Cr capex bet has yet to execute.

From the numbers. The trailing PE of 41.5x sits at the 0th percentile of the available 5-quarter PE history, with the peak being 77.1x in Jun 2025. The matrix_label is EMERGING_OPPORTUNITY and segment EXPANSION_STARTED, but…

From the price. Price stage 2, week 18 — above its 200-day line, relative strength rising.

From the research. A specialty-fats compounder that delivered 76% FY26 revenue growth — but margins are at a 74th-percentile peak (cycle_normalized: PEAK_MARGIN_VALUE_TRAP), management has accrued seven cross-call contradictions across…

🚨 Where they disagree. The trailing PE of 41.5x sits at the 0th percentile of the available 5-quarter PE history, with the peak being 77.1x in Jun 2025. The matrix_label is EMERGING_OPPORTUNITY and segment EXPANSION_STARTED, but data_sufficiency is LIMITED and low_reliability is flagged — this is a thin-data cycle read, not a verified trough. The critical overlay from cycle_normalized: OPM at the 74th percentile of 7-year history means trailing EPS of ₹37.95 is inflated by peak margins; at mid-cycle OPM of 17.3% the normalized PE rises to 66x (81st percentile). The trailing compressed PE is an earnings-peak illusion, not a cycle trough. Institutional signal is DII_SELLING, and the durability operating_cycle.stage…

What is proven. A specialty-fats compounder that delivered 76% FY26 revenue growth — but margins are at a 74th-percentile peak (cycle_normalized: PEAK_MARGIN_VALUE_TRAP), management has accrued seven cross-call contradictions across four concalls, and the ₹460 Cr capex bet has yet to execute.

What is not proven yet. Trailing PE of 41.5x looks compressed (36th %ile) but at mid-cycle OPM the normalized PE is 66x (81st %ile) — the low multiple is an EPS-inflated illusion, not a trough.

Layer 1 read, 19 July 2026 — KEEP. Real +77% growth story, but the cheap PE is peak-margin-flattered and management keeps missing its own targets. Manorama's earnings are genuinely expanding — revenue ₹195→₹391 Cr and EPS ₹4.32→₹8.79 over seven quarters [C008/C009] — so it is not a value trap, but the optically cheap 41.5x PE (36th percentile) becomes 66x at the 81st percentile once you normalize the 74th-percentile peak OPM, and Mar-2026 already printed the first margin and EPS dip. Seven cross-call management contradictions and promoter selling cap conviction at Silver despite the strong headline delivery.

What would change Layer 1’s mind. Sharpening the timeline's own signal: OPM printing below 25% for two consecutive quarters would confirm the peak-margin rollover has begun and the 'cheap' trailing PE is an illusion [thesis / C015] — flipping this from a real growth story toward the trap; conversely, debottlenecking delivering the guided 25-30% FY27 volume growth at sustained OPM would push it back toward P1.

Layer 2 read, 19 July 2026 — ADVANCE. A real, externally-confirmed specialty-fats moat riding a structural cocoa-substitution tailwind — advance, but with no valuation cushion and a management-credibility flag. Independent sources confirm the engine is real: SOIC (reliability 1.0) calls out margins 'holding despite the cocoa crash' with a years-to-build waste-to-wealth procurement moat, and Manorama is one of only ~7 global CBE producers — the demand behind FY26 revenue +77% and PAT +105% and an EXPANDING earnings curve (r2 0.86). The caution is valuation and management: the optically cheap 41.5x PE becomes 66x at the 81st percentile on mid-cycle margins, margins already dipped one quarter, and management has 7 cross-call contradictions. So I advance the genuine growth but cap it at P2 conviction.

What would change Layer 2’s mind. A second consecutive quarter of OPM contraction below the mid-cycle band (extending the Mar-2026 dip) confirming the peak-margin trap is playing out, OR an eighth material management guidance reversal / a governance disclosure from a Tier-1 source on the promoter selling — either would flip ADVANCE→DROP. Conversely, on-time execution of the ₹460 Cr capex with margins holding would lift conviction toward P1.

Layer 3 read, 19 July 2026 — BENCH. Real 76% growth, but management contradicts itself 7 times, promoters are trimming, and there's no valuation cushion at peak margins — BENCH. The growth is genuine (FY26 revenue +76%, PAT +105%) and revenue guidance has been beaten-and-raised every time, so this is not a DROP. But management has logged seven cross-call contradictions across four concalls — working-capital targets abandoned, capex funding pivoted twice, debottlenecking slipped a full year — pushing disclosure-consistency to 2.5/10 and mgmt to WATCHLIST. With promoters trimming 57.26%->54.32%, a ₹460 Cr capex bet with zero milestones met, and margins at a 74th-percentile peak (normalized PE 66x) with negative MoS, there is no cushion to admit a WATCHLIST-management P2 to the deploy book now.

What would change Layer 3’s mind. Promoter stake STABILIZING or rising (buying-through-the-run conviction) AND management resolving ≥2 of the seven contradictions with the ₹460 Cr capex hitting a first real milestone — that would lift mgmt from WATCHLIST toward PASS and flip BENCH to DEPLOY. Conversely, an eighth contradiction or a further promoter reduction escalates governance and pushes toward DROP.

The test written in advance. PEAK_MARGIN_VALUE_TRAP — OPM at 74th percentile of 7-year history — PEAK_MARGIN_VALUE_TRAP — OPM at 74th percentile of 7-year history OPM below 25% for two consecutive quarters or concall commentary signaling input cost pressure / pricing rollback by the next result.

The test written in advance. Management guidance discipline — 7 cross-call contradictions across 4 concalls — Management guidance discipline — 7 cross-call contradictions across 4 concalls by the next result.

The test written in advance. Capex execution risk — ₹460 Cr programme, zero timeline commitments met — Capex execution risk — ₹460 Cr programme, zero timeline commitments met FY27 capex deployment pace — guide is ₹100-150 Cr; any shortfall against this re-tests the FY28 completion date by the next result.

🚨 What the surface reading misses. The surface reading is: FY26 OCF/PAT 1.11x looks strong vs FY25's -0.52x The research reads it further: The FY26 OCF improvement was driven by inventory days compressing from 518 to 362 (a -156 day swing) — the reversal of a prior seasonal bulk-procurement build. This is a timing-driven release, not a structural improvement in cash conversion. The 3-year OCF/PAT aggregate remains 0.58x, which the why_guards.wc_model=distributor_inventory identifies as the expected model for a seasonal bulk-inventory business. Debt fell ₹126 Cr to ₹356 Cr — capital is not subsidizing the cash, the working capital cycle provided the release.

Lever 1 · Operating leverage — BUILDING. EBITDA margin moved from a 14-17% underutilization band to 25-27% post-July-2024 and has held there for six consecutive quarters as revenue compounds at 50-80% YoY. What proves it keeps working: Operating Leverage / Margin Step-Up. It stops working if OPM below 25% for two consecutive quarters or concall commentary signaling input cost pressure / pricing rollback.

Lever 2 · Value-added mix — BUILDING. CBE scaled from 10% to 30% of revenue over two years; value-added products now 75% of total sales, with a stated path to 85-90% in 1-2 years. What proves it keeps working: CBE and Value-Added Product Mix Shift. It stops working if OPM below 25% for two consecutive quarters or concall commentary signaling input cost pressure / pricing rollback.

Lever 6 · Order-book wins — BUILDING. ₹460 Cr across CBA (75k MT), fractionation 3 (75k MT), refinery expansion (90k MT), and West Africa backward integration (120 Cr), targeting >6x asset turnover on the forward-integration subset — but not a single capacity timeline commitment has been met on schedule yet. What proves it keeps working: ₹460 Cr Four-Pillar Integration Capex. It stops working if OPM below 25% for two consecutive quarters or concall commentary signaling input cost pressure / pricing rollback.

Lever 14 · A bigger market to sell into — BUILDING. The specialty-fats market has a structural demand-supply gap; hundreds of customer relationships with application-specific formulation lock-in create pricing power independent of commodity cycles. What proves it keeps working: Undersupplied Specialty-Fats TAM with Customer Lock-in. It stops working if OPM below 25% for two consecutive quarters or concall commentary signaling input cost pressure / pricing rollback.

Sources: our stock research file (14 June 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Manorama Industries Ltd reported ₹404 Cr of revenue in the Jun 26 quarter, +39.3% year on year. That is the 12th straight quarter of year-on-year growth. Over 1 years it has compounded at 77.3% a year. The last full year, FY26, came in at ₹1,367 Cr. The last four reported quarters add to ₹1,481 Cr.

Why this happened. ₹460 Cr across CBA (75k MT), fractionation 3 (75k MT), refinery expansion (90k MT), and West Africa backward integration (120 Cr), targeting >6x asset turnover on the forward-integration subset — but not a single capacity timeline commitment has been met on schedule yet.

FY26 revenue came in at ₹1,367 Cr (+77.3% on the year), capping 1 years at 77.3% compound. The latest quarter (Jun 26) printed ₹404 Cr, +39.3% year on year — the 12th consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +61.6% growth against the decade's 77.3% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +59.8% over the last 4 quarters against +76.0%/yr over the last 8 — rolling over; TTM profit +80.4% vs +144.9%/yr — rolling over.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Manorama Industries Ltd's operating margin is 26.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago.

Why this happened. The re-rating driver of the past six quarters. Management states the prior 14-16% margins reflected facility underutilization resolved after the July-2024 optimization, and that 25-27% EBITDA is now the sustainable range. The quarterly OPM trajectory confirms: 22.6% (Sep 2024) → 25.9% (Dec 2024) → 26.3% (Mar 2025) → 25.8% (Jun 2025) → 27.1% (Sep 2025) → 28.2% (Dec 2025) → 24.9% (Mar 2026). The Mar 2026 dip to 24.9% is the first print below 25% in six quarters and deserves monitoring — cycle_normalized flags OPM at the 74th percentile, signaling peak-zone territory. Gross margin is held in a 42-51% range with quarterly swings attributed to byproduct realization and freight. The driver is…

The latest quarter's operating margin is 26.0%, +0.0 pp against the same quarter a year ago. Across 2 fiscal years the operating margin has ranged 24.0%–26.0%.

Why the margin moved: operating margin went +0.5 pp year on year while gross margin went −3.8 pp — the gain came mostly from the gross line: input costs and pricing.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Manorama Industries Ltd earned ₹79.0 Cr of net profit in the Jun 26 quarter, +68.1% year on year. It is the 10th consecutive quarter of growth. Full-year FY26 profit was ₹225 Cr. The 1-year compound rate is 104.5%. That is 19.6% of the quarter's revenue. The same quarter a year earlier earned ₹47.0 Cr.

Jun 26 profit was ₹79.0 Cr, +68.1% year on year — the 10th consecutive quarter of growth. On the full year, FY26 printed ₹225 Cr (+104.5%), and the 1-year compound rate is 104.5%.

Why profit moved: revenue contributed +39.3% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +87.4% vs revenue +61.6%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 2 fiscal years 58% of Manorama Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹250 Cr of operating cash against ₹225 Cr of profit. After ₹59.0 Cr of capital spending, ₹191 Cr was left as free cash.

FY26: operating cash of ₹250 Cr against reported profit of ₹225 Cr, leaving free cash of ₹191 Cr after ₹59.0 Cr of capital spending. Across the last 2 fiscal years the conversion rate is 58% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

🚨 Why conversion sits at 58%: the cash cycle tightened 218 days between FY25 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: the bigger cash user is investment — capital spending ran 2.3× depreciation over three years, so the next section's job is to check what that build-out is buying.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Manorama Industries Ltd's cash conversion cycle runs 334 days in FY26, down from 552 days in FY25. Capital spending ran ₹59.0 Cr over the last 1 years. At FY26 sales of ₹1,367 Cr each day of that cycle holds about ₹3.7 Cr, so roughly ₹1,251 Cr sits inside the business at any moment.

FY26: debtors at 17 days, inventory at 362 days — roughly 11.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 334 days, tighter than FY25's 552.

The full loop: cash goes out to suppliers and production on day 0; stock waits 362 days to sell; customers pay about 17 days after that; and suppliers themselves are paid at 45 days — netting out to the 334-day cycle.

In money terms: at FY26 sales of ₹1,367 Cr, each day of the cycle holds about ₹3.7 Cr — so the 334-day loop keeps roughly ₹1,251 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹59.0 Cr over the last 1 fiscal years against ₹26.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹18.0 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Manorama Industries Ltd earns a ROCE of 35% in FY26. Return on invested capital clears the cost of that capital by +16.3 percentage points, so growth here adds value rather than only size. The wiring behind it is 16.5% net margin on 1.14× asset turns.

FY26 ROCE is 35%.

Why the return is what it is — the wiring (FY26): 16.5% net margin × 1.14× asset turns × 1.76× balance-sheet leverage ≈ 33.1% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 28.3% − 12.0% = a +16.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Manorama Industries Ltd carries total debt of ₹356 Cr against shareholder equity of ₹682 Cr as of Mar 26, a debt-to-equity of 0.52. On the annual view that ratio went from 0.40 in FY22 to 0.52 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹356 Cr against shareholder equity of ₹682 Cr — a debt-to-equity of 0.52. On the annual view, debt-to-equity went from 0.40 (FY22) to 0.52 (FY26). Read the returns on this page with that leverage in mind.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Promoters cut 2.9 points of Manorama Industries Ltd over 8 quarters, the biggest move on the register. That takes promoters to 54.3% of the company. Foreign institutions moved +1.1 points over the same window, to 3.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: −2.9 points over 8 quarters to 54.3%; Foreign institutions: +1.1 points over 8 quarters to 3.2%; Domestic institutions: +0.9 points over 8 quarters to 2.6%.

🚨 Why the register moved: promoters drove it (−2.9 points), absorbed on the other side by foreign institutions (+1.1 points) — distribution into the market’s bid.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Manorama Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Manorama Industries Ltd trades at 42.5× P/E, mid-range by its own standards (46th percentile). Its long-run median P/E is 44.1×, measured across 1.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 42.5× is mid-range by its own standards (46th percentile), against a long-run median of 44.1× measured over 1.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +104.5% against a +26.2% price move — earnings outran the price, pushing the multiple DOWN its own range.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Manorama Industries Ltd reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: revenue growth has eased from +90.1% at its peak to +59.8% but is still expanding, ROCE lifting at 56.0%. The read is built from 12 quarters across 4 curves, on full evidence.

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

4-Factor Sector Score

76.5/100 — rank 1 of 2 in FMCG - Chocolate · 90% evidence confidence

Manorama Industries Ltd scores 76.5 out of 100 against the 2 companies it is compared with in FMCG - Chocolate, ranking 1. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.

The four contributions add to the total exactly: 30.8 + 20 + 13.2 + 12.5 = 76.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Said versus delivered

What Manorama Industries Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.

Dekel/Brazil Operating Status Reversal · 14 August 2026. In May 2026, management said Dekel had begun operating and reported subsidiary revenue and losses. In Aug 2026, management said operations had not yet started and declined to provide revenue from the Dekel entity, creating a material inconsistency about the unit's commercial status and contribution.

Numeric FY27 Growth Guidance No Longer Reaffirmed · 14 August 2026. In Jan 2026, management indicated that FY27 growth should be above 30%, while the Aug 2026 call declined to provide an absolute revenue guide and redirected investors to model results themselves. The latest call still expresses confidence in healthy growth, but removes the earlier quantitative anchor that would affect revenue and valuation models.

Africa Geopolitical Risk Narrative Became Less Categorical · 14 August 2026. In May 2026, management gave a categorical assurance that political uncertainty would not affect the Burkina Faso project or African operations. In Aug 2026, management acknowledged that geopolitical factors could impact the company directly and affect freight, logistics, and other macroeconomic factors; although diversification was cited as mitigation, the latest call did not explain the change in risk assessment.

Working Capital Target Abandoned · 12 May 2026. In Oct 2025, management set an aspirational target of 75 days for the working capital cycle within the next two years, and in Jan 2026 revised that target to 90-100 days citing benefits from the upcoming new capacity. In the May 2026 full-year call, management reported a 125-day working capital cycle for FY26 and guided to simply maintain that level going forward, effectively abandoning both prior commitments without any acknowledgement or explanation of the reversal.

Every quote above is taken word for word from the company’s own earnings calls.

Frequently asked questions